Safety of long-term nucleos(t)ide treatment in chronic hepatitis B
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14740338.2012.672972
Reference16 articles.
1. Chronic hepatitis B: Update 2009
2. EASL Clinical Practice Guidelines: Management of chronic hepatitis B
3. A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B
4. Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
5. Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end‐of‐life: A scoping review;Health & Social Care in the Community;2022-10-19
2. Probability of HBsAg Loss After Nucleo(s)tide Analogue Withdrawal Depends on HBV Genotype and Viral Antigen Levels;Journal of Clinical and Experimental Hepatology;2022-09
3. Effectiveness and Safety of Low Dose of Tenofovir Disoproxil Fumarate in Malagasy Patients with Chronic Hepatitis B;BioMed Research International;2022-05-31
4. Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development;Nature Communications;2020-09-23
5. Entecavir and tenofovir on renal function in patients with hepatitis B virus‐related hepatocellular carcinoma;Journal of Viral Hepatitis;2020-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3